MOUNTAIN VIEW, Calif., Sept. 26 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq:IRIX) today announced that it has introduced its new OcuLight OR (532 nm) green laser which expands its existing OcuLight product line offering and allows the Company to enter the Ear, Nose and Throat (ENT) market. This new, solid-state laser system can be used in the operating room environment by otologists for otosclerosis and by ophthalmologists for retinal photocoagulation which will allow hospitals to use one standard laser platform across specialties and one laser console to satisfy operating room needs.
Barry G. Caldwell, President and CEO of IRIDEX, said, "The OcuLight OR laser capitalizes on our experience with ophthalmic solid-state laser technology and our presence in the operating room, allowing us to serve both ophthalmic and ENT needs. Our technology will allow operating rooms to standardize one laser platform across both medical specialties. We believe this new system could potentially expand our laser console sales while allowing us to evaluate additional opportunities for our technology within the ENT market."
The laser was shown to otologists for the first time this past weekend at the American Academy of Otolaryngologists meeting held in Los Angeles, California. It was very positively received by the otology subspecialty.
The OcuLight OR laser is the newest addition to the OcuLight green product family manufactured by IRIDEX. The OcuLight family is widely accepted for its reliability, performance, ease of use, and portability and it makes up the world's largest installed base of solid-state ophthalmic lasers. The OcuLight OR laser was specifically designed for the operating room environment and contains a user-friendly control interface. The laser features bright LED displays and large easy-to-read labeling. The laser is energy efficient and does not require regular laser maintenance or special electrical or plumbing as seen with older tube-based technology.
The OcuLight OR is compatible with laser indirect ophthalmoscopes and endophotocoagulation probes as delivery device options for ophthalmologists to perform retinal photocoagulation procedures. The OcuLight OR is also compatible with short and long angle probes for otologists to perform stapedectomy/stapedotomy procedures. A variety of filter models with superior color balance and tissue visualization are also available.
About IRIDEX
IRIDEX Corporation is a leading worldwide provider of semiconductor-based laser systems for the ophthalmology and dermatology markets. IRIDEX products are sold in the United States through a direct sales force and internationally through a network of independent distributors into more than 100 countries. For further information, visit the Company's website at www.iridex.com.
Safe Harbor Statement
This press release contains forward-looking statements that involve risks and uncertainties, including statements relating to the IRIDEX' market opportunity and future business prospects. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. Factors that could cause actual results to differ from the results predicted are included in IRIDEX' quarterly reports on Form 10-Q and from time to time in other reports filed by IRIDEX with the Securities and Exchange Commission.
SOURCE IRIDEX Corporation
-0- 09/26/2005
/CONTACT: Larry Tannenbaum, Chief Financial Officer of IRIDEX
Corporation, +1-650-940-4700/
/Web site: http://www.iridex.com /
(IRIX)
CO: IRIDEX Corporation
ST: California
IN: CPR SEM MTC HEA ECP
SU: PDT
TX-UC
-- SFM130 --
0930 09/26/2005 17:53 EDT http://www.prnewswire.com
